US Stock MarketDetailed Quotes

ACRV Acrivon Therapeutics

Watchlist
  • 7.590
  • +0.040+0.53%
Close Jul 23 16:00 ET
  • 7.590
  • 0.0000.00%
Post 16:00 ET
234.36MMarket Cap-2626P/E (TTM)

Acrivon Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-50.42%-17.08M
-41.58%-42.64M
-32.20%-12.37M
-50.38%-9.81M
-56.46%-9.11M
-34.91%-11.36M
-115.40%-30.12M
-157.90%-9.35M
-181.81%-6.52M
-5.82M
Net income from continuing operations
-29.24%-16.49M
-93.76%-60.39M
-115.61%-19.25M
-57.27%-14.47M
-139.07%-13.91M
-76.68%-12.76M
-91.88%-31.17M
-105.60%-8.93M
-276.97%-9.2M
---5.82M
Depreciation and amortization
79.20%224K
47.25%536K
19.20%149K
14.66%133K
65.38%129K
177.78%125K
883.78%364K
861.54%125K
1,188.89%116K
--78K
Other non cash items
17.28%224K
6.43%778K
3.19%194K
7.61%198K
7.73%195K
7.30%191K
-36.10%731K
-6.93%188K
-26.98%184K
--181K
Change In working capital
-786.51%-3.81M
631.20%8.14M
323.09%4.17M
-19.59%1.84M
616.13%2.56M
70.57%-430K
-567.07%-1.53M
-1,424.11%-1.87M
3,083.33%2.29M
---496K
-Change in prepaid assets
-76.39%140K
159.62%2.11M
106.73%168K
-105.10%-74K
188.28%1.42M
167.08%593K
-363.22%-3.54M
-295.40%-2.5M
1,849.40%1.45M
---1.61M
-Change in payables and accrued expense
-342.57%-3.75M
153.63%6.78M
423.63%4.21M
107.52%2.1M
3.28%1.32M
-101.43%-848K
60.70%2.67M
-22.32%804K
262.37%1.01M
--1.28M
-Change in other current liabilities
-13.71%-199K
-13.04%-754K
-21.02%-213K
-5.85%-181K
-12.80%-185K
-12.18%-175K
-16.61%-667K
33.08%-176K
-37.90%-171K
---164K
Cash from discontinued investing activities
Operating cash flow
-50.42%-17.08M
-41.58%-42.64M
-32.20%-12.37M
-50.38%-9.81M
-56.46%-9.11M
-34.91%-11.36M
-115.40%-30.12M
-157.90%-9.35M
-181.81%-6.52M
---5.82M
Investing cash flow
Cash flow from continuing investing activities
-37.28%5.85M
135.80%50.72M
121.60%20.54M
103.36%1.52M
1,900.56%19.34M
2,347.47%9.33M
-59,427.73%-141.68M
-69,291.97%-95.07M
-45.12M
-1.07M
Net PPE purchase and sale
-3,160.00%-815K
40.54%-1.29M
-358.57%-1.15M
--0
89.57%-112K
93.98%-25K
-810.08%-2.17M
-83.21%-251K
---426K
---1.07M
Net investment purchase and sale
-28.73%6.67M
137.28%52.01M
122.87%21.69M
103.39%1.52M
--19.45M
--9.35M
---139.51M
---94.82M
---44.69M
--0
Cash from discontinued investing activities
Investing cash flow
-37.28%5.85M
135.80%50.72M
121.60%20.54M
103.36%1.52M
1,900.56%19.34M
2,347.47%9.33M
-59,427.73%-141.68M
-69,291.97%-95.07M
---45.12M
---1.07M
Financing cash flow
Cash flow from continuing financing activities
-172K
-101.53%-1.55M
-101.97%-2.01M
155.71%78K
379K
0
-9.37%101.71M
2.11%101.86M
-14,100.00%-140K
Net common stock issuance
----
--0
----
----
----
----
--104.46M
----
----
----
Proceeds from stock option exercised by employees
--79K
3,129.17%775K
--318K
225.00%78K
--379K
--0
2,300.00%24K
--0
--24K
----
Net other financing activities
---251K
16.01%-2.33M
----
----
----
----
---2.77M
---2.6M
---164K
----
Cash from discontinued financing activities
Financing cash flow
---172K
-101.53%-1.55M
-101.97%-2.01M
155.71%78K
3,545.45%379K
--0
-9.37%101.71M
2.11%101.86M
-14,100.00%-140K
---11K
Net cash flow
Beginning cash position
21.81%36.43M
-70.09%29.91M
-6.77%30.27M
-54.32%38.48M
-69.42%27.88M
-70.09%29.91M
4,924.67%99.99M
711.29%32.47M
1,234.11%84.25M
--91.16M
Current changes in cash
-461.82%-11.41M
109.31%6.52M
340.49%6.16M
84.14%-8.21M
253.50%10.61M
77.02%-2.03M
-171.51%-70.08M
-102.67%-2.56M
-2,138.69%-51.78M
---6.91M
End cash Position
-10.23%25.02M
21.81%36.43M
21.81%36.43M
-6.77%30.27M
-54.32%38.48M
-69.42%27.88M
-70.09%29.91M
-70.09%29.91M
711.29%32.47M
--84.25M
Free cash flow
-57.25%-17.9M
-36.07%-43.93M
-40.73%-13.52M
-41.15%-9.81M
-33.72%-9.22M
-28.86%-11.38M
-127.03%-32.28M
-155.18%-9.61M
-200.22%-6.95M
---6.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -50.42%-17.08M-41.58%-42.64M-32.20%-12.37M-50.38%-9.81M-56.46%-9.11M-34.91%-11.36M-115.40%-30.12M-157.90%-9.35M-181.81%-6.52M-5.82M
Net income from continuing operations -29.24%-16.49M-93.76%-60.39M-115.61%-19.25M-57.27%-14.47M-139.07%-13.91M-76.68%-12.76M-91.88%-31.17M-105.60%-8.93M-276.97%-9.2M---5.82M
Depreciation and amortization 79.20%224K47.25%536K19.20%149K14.66%133K65.38%129K177.78%125K883.78%364K861.54%125K1,188.89%116K--78K
Other non cash items 17.28%224K6.43%778K3.19%194K7.61%198K7.73%195K7.30%191K-36.10%731K-6.93%188K-26.98%184K--181K
Change In working capital -786.51%-3.81M631.20%8.14M323.09%4.17M-19.59%1.84M616.13%2.56M70.57%-430K-567.07%-1.53M-1,424.11%-1.87M3,083.33%2.29M---496K
-Change in prepaid assets -76.39%140K159.62%2.11M106.73%168K-105.10%-74K188.28%1.42M167.08%593K-363.22%-3.54M-295.40%-2.5M1,849.40%1.45M---1.61M
-Change in payables and accrued expense -342.57%-3.75M153.63%6.78M423.63%4.21M107.52%2.1M3.28%1.32M-101.43%-848K60.70%2.67M-22.32%804K262.37%1.01M--1.28M
-Change in other current liabilities -13.71%-199K-13.04%-754K-21.02%-213K-5.85%-181K-12.80%-185K-12.18%-175K-16.61%-667K33.08%-176K-37.90%-171K---164K
Cash from discontinued investing activities
Operating cash flow -50.42%-17.08M-41.58%-42.64M-32.20%-12.37M-50.38%-9.81M-56.46%-9.11M-34.91%-11.36M-115.40%-30.12M-157.90%-9.35M-181.81%-6.52M---5.82M
Investing cash flow
Cash flow from continuing investing activities -37.28%5.85M135.80%50.72M121.60%20.54M103.36%1.52M1,900.56%19.34M2,347.47%9.33M-59,427.73%-141.68M-69,291.97%-95.07M-45.12M-1.07M
Net PPE purchase and sale -3,160.00%-815K40.54%-1.29M-358.57%-1.15M--089.57%-112K93.98%-25K-810.08%-2.17M-83.21%-251K---426K---1.07M
Net investment purchase and sale -28.73%6.67M137.28%52.01M122.87%21.69M103.39%1.52M--19.45M--9.35M---139.51M---94.82M---44.69M--0
Cash from discontinued investing activities
Investing cash flow -37.28%5.85M135.80%50.72M121.60%20.54M103.36%1.52M1,900.56%19.34M2,347.47%9.33M-59,427.73%-141.68M-69,291.97%-95.07M---45.12M---1.07M
Financing cash flow
Cash flow from continuing financing activities -172K-101.53%-1.55M-101.97%-2.01M155.71%78K379K0-9.37%101.71M2.11%101.86M-14,100.00%-140K
Net common stock issuance ------0------------------104.46M------------
Proceeds from stock option exercised by employees --79K3,129.17%775K--318K225.00%78K--379K--02,300.00%24K--0--24K----
Net other financing activities ---251K16.01%-2.33M-------------------2.77M---2.6M---164K----
Cash from discontinued financing activities
Financing cash flow ---172K-101.53%-1.55M-101.97%-2.01M155.71%78K3,545.45%379K--0-9.37%101.71M2.11%101.86M-14,100.00%-140K---11K
Net cash flow
Beginning cash position 21.81%36.43M-70.09%29.91M-6.77%30.27M-54.32%38.48M-69.42%27.88M-70.09%29.91M4,924.67%99.99M711.29%32.47M1,234.11%84.25M--91.16M
Current changes in cash -461.82%-11.41M109.31%6.52M340.49%6.16M84.14%-8.21M253.50%10.61M77.02%-2.03M-171.51%-70.08M-102.67%-2.56M-2,138.69%-51.78M---6.91M
End cash Position -10.23%25.02M21.81%36.43M21.81%36.43M-6.77%30.27M-54.32%38.48M-69.42%27.88M-70.09%29.91M-70.09%29.91M711.29%32.47M--84.25M
Free cash flow -57.25%-17.9M-36.07%-43.93M-40.73%-13.52M-41.15%-9.81M-33.72%-9.22M-28.86%-11.38M-127.03%-32.28M-155.18%-9.61M-200.22%-6.95M---6.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg